QUALITY OF LIFE ANALYSIS OF PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER WHO UNDERWENT UROLOGICAL PALLIATIVE TREATMENT
QUALITY OF LIFE ANALYSIS OF PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER WHO UNDERWENT UROLOGICAL PALLIATIVE TREATMENT
This is an automatically generated default intro template – please do not edit.
|
General information |
|
| Title: | QUALITY OF LIFE ANALYSIS OF PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER WHO UNDERWENT UROLOGICAL PALLIATIVE TREATMENT |
| Meta keywords: | |
| Meta description: | |
|
Images information |
|
| Images path absolute: | /home/jmedarr/public_html/images/stories/com_form2content/p2/f420 |
| Images path relative: | com_form2content/p2/f420 |
| Thumbs path absolute: | |
| Thumbs path relative: | |
|
Fields information |
|
| Article_Title: | QUALITY OF LIFE ANALYSIS OF PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER WHO UNDERWENT UROLOGICAL PALLIATIVE TREATMENT |
| Authors: | Adrian Crișan1,3, Horia Dan Mureșanu1,2, Imola Miklos 2, Paul Deme 1, Ioan Ioiart1, 2 |
| Affiliation: | 1 Western University ”Vasile Goldiș” Arad 2 Arad County Emergency Hospital Urology Clinic 3 Arad County Emergency Hospital Intensive Care Unit |
| Abstract: | Prostate cancer is one of the most frequent malignancies in the world. Its incidence is in continuous growth especially in developed countries.There isn’t a clear evidence of the patients with prostate cancer in Arad county. The aim of this study is to assess the improving of patients’ qol after they underwent different types of urological palliative treatment. This study is a prospective one and it comprises 71 patients, diagnosed with CRPC who underwent urological palliative treatment.Our results show higher incidence of castrate resistant prostate cancer (CRPC) in patients from urban areas. The main urological palliative treatment applied to the patients was the transurethral resection of the prostate. Our study demonstrates the improving of the quality of life (QoL) after urinary drainage, we found an important improving of the ECOG scor. |
| Keywords: | Qol, CRPC, nephrostomy |
| References: | Alemayehu B, Buysman E, Parry D, Becker L, Nathan F, Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population, J Med Econ 13:351–361, 2010. Cabrera C, Hirst C, Hayflinger C, Koo L, Co-morbidity among hormone resistant prostate cancer patients in the US. Pharmacoepidemiol Drug Safety 19(A615):S1–S347, 2010. Damber JE. Castration resistant prostate cancer comprises a heterogeneous group of both symptomatic and asymptomatic patients with or without clinical metastases. Endocrine therapy for prostate cancer. Acta Oncol. 44, 605–609, 2005. Scher HI, Halabi S, Tannock I, Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J. Clin. Oncol. 26, 1148–1159, 2008. |
| Read_full_article: | pdf/vol19/iss3/4 JMA 2016 – Crisan.pdf |
| Correspondence: | Arad County Emergency Hospital, str. Andrenyi Karolyi nr. 2-4, Arad, Romania Tel: 0722842370 E-mail: adriancrisan74@yahoo.com |
 |
Read full article | |
| Article Title: | QUALITY OF LIFE ANALYSIS OF PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER WHO UNDERWENT UROLOGICAL PALLIATIVE TREATMENT | |
| Authors: |
|
|
| Affiliation: | 1 Western University ”Vasile Goldiș” Arad 2 Arad County Emergency Hospital Urology Clinic 3 Arad County Emergency Hospital Intensive Care Unit |
|
| Abstract: | Prostate cancer is one of the most frequent malignancies in the world. Its incidence is in continuous growth especially in developed countries.There isn’t a clear evidence of the patients with prostate cancer in Arad county. The aim of this study is to assess the improving of patients’ qol after they underwent different types of urological palliative treatment. This study is a prospective one and it comprises 71 patients, diagnosed with CRPC who underwent urological palliative treatment.Our results show higher incidence of castrate resistant prostate cancer (CRPC) in patients from urban areas. The main urological palliative treatment applied to the patients was the transurethral resection of the prostate. Our study demonstrates the improving of the quality of life (QoL) after urinary drainage, we found an important improving of the ECOG scor. | |
| Keywords: | Qol, CRPC, nephrostomy | |
| References: | Alemayehu B, Buysman E, Parry D, Becker L, Nathan F, Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population, J Med Econ 13:351–361, 2010. Cabrera C, Hirst C, Hayflinger C, Koo L, Co-morbidity among hormone resistant prostate cancer patients in the US. Pharmacoepidemiol Drug Safety 19(A615):S1–S347, 2010. Damber JE. Castration resistant prostate cancer comprises a heterogeneous group of both symptomatic and asymptomatic patients with or without clinical metastases. Endocrine therapy for prostate cancer. Acta Oncol. 44, 605–609, 2005. Scher HI, Halabi S, Tannock I, Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J. Clin. Oncol. 26, 1148–1159, 2008. |
|
| *Correspondence: | Arad County Emergency Hospital, str. Andrenyi Karolyi nr. 2-4, Arad, Romania Tel: 0722842370 E-mail: adriancrisan74@yahoo.com |
PREVALENCE OF ERECTILE DYSFUNCTION POST-STROKE, AND ASSOCIATED RISK FACTORS AND CO-MORBIDITIES
THE IMPLICATIONS OF LYMPHANGIOGENESIS IN LUNG SQUAMOUS CELL CARCINOMAS
UTERINE ARTERY DOPPLER FLOW INDICES IN PREGNANT WOMEN DURING THE 21 WEEKS + 0 DAYS AND 23 WEEKS + 6 DAYS GESTATIONAL AGES: A STUDY OF 115 PATIENTS
About The Author
